[Histonet] Dako 2008 Beckman Coulter and Milestones
akemiat3377 <@t> yahoo.com
Thu Mar 12 17:48:42 CDT 2009
Dako was not purchased by Danaher. FYI.. Read posted Milestones from Dako's website below:
Akemi Allison-Tacha BS, HT (ASCP) HTL
Phoenix Lab Consulting
Specializing in Histology, SS, IHC, & TMA
Tele: (425) 941-4287
E-Mail: akemiat3377 <@t> yahoo.com
Beckman Coulter buys Dako’s Flow Business Unit
Dako’s Flow Business Unit in Colorado, USA has been sold to Beckman Coulter. Thereby Dako’s focus on anatomic pathology, tissue-based cancer diagnostics and reagents for flow cytometry is strengthened.
Dako launches Dako Link - Integrated Workflow Solutions
Never before has Dako launched so many important products at one time. The Dako Link solution offers software, instruments, reagents and connectivity options customized to meet the needs of any pathology laboratory. Dako Link substantially improves cost efficiency and turnaround time in the lab by linking together the entire workflow.
Dako gets new owner
Private equity fund EQT V (“EQT”) has signed a definitive agreement to acquire 100% of Dako. The total consideration for the transaction is DKK 7.25 billion.
Dako launches ACIS® III
Dako launches the newest addition to our growing portfolio of automated platforms, ACIS® III. With a new sophistication, ACIS® IIII is enhancing the lab’s workflow to include advanced image analysis benefits in a simple manner. Pathologists now have the capability to improve their workflow, turnaround time, and experience cost savings.
Dako's Microbiology business sold
The sale of the microbiology activities to Oxoid is part of Dako’s strengthened focus on anatomic pathology. Dako’s microbiology range will gradually be rebranded as Oxoid and products should be ordered via Oxoid.
Change of name
The company changes its name from DakoCytomation A/S to Dako A/S.
Microbiology up for sale
DakoCytomation sharpens its focus on cancer diagnostics by putting its Microbiology activities up for sale.
Agreement on image analysis
DakoCytomation enters an agreement with Clarient Inc. on the further development and sale of its ACIS instruments, which are used for image analysis. The agreement is part of Dako’s strategy to automate more areas of the workflow in the pathology laboratory and to offer more integrated systems to the market for cancer diagnostics.
Acquires instrument business
DakoCytomation acquires the Artisan™ instrument business from CytoLogix Inc. Artisan™ is a state-of-the-art tissue staining instrument.
Merges with bioinstrumentation company Cytomation and becomes DakoCytomation
DAKO, the world-leading producer of cancer diagnostic reagents, merges with the Fort Collins-based bioinstrumentation company Cytomation Inc. The purpose of the merger is for the two companies to utilize their common competencies to further strengthen their position in the fast-growing market segments of the in vitro diagnostics industry. Cytomation was originally founded in 1988 in Colorado by one American and three Australian scientists who were convinced that the industry-standard flow cytometer could do a better job.
Sells Boston Probes
DAKO sells Boston Probes Inc. to Applied Biosystems Inc.
Expands into PNA technology
DAKO co-founds Boston Probes Inc. with the purpose of expanding into PNA technology, a supplementary technology to the traditional DNA technology.
Danish pharmaceutical company Novo Nordisk A/S invests in DAKO
Acquires Novo Nordisk Diagnostics
DAKO acquires Novo Nordisk Diagnostics (activities in microbiology) in Cambridge, United Kingdom.
DAKOPATTS changes name to DAKO
In the 1980s DAKOPATTS establishes more sales subsidiaries around the world. Today the company has a total of 22 subsidiaries.
Enters the USA
DAKOPATTS Corporation is founded in the USA.
Founded in Denmark
DAKOPATTS is founded in Denmark. DAKOPATTS’ initial product series was purified polyclonal antibodies.
More information about the Histonet